Access to Care for Patients With Insulin-Requiring Diabetes in Developing Countries
Open accessAbstract
OBJECTIVE—The objective of this study was to assess the barriers to care for patients with insulin-requiring diabetes in Mozambique and Zambia. RESEARCH DESIGN AND METHODS—We used the Rapid Assessment Protocol for Insulin Access to collect information through interviews, discussions, site visits, and document reviews. Government organizations, health facilities, care givers, and patients were asked about care for people with insulin-requiring diabetes. Between 100 and 200 interviews/discussions per country were undertaken in and around the capital city and the regional capital and in a rural area. RESULTS—Insulin was present in both countries in sufficient quantities, although the financial burden for health services and patients meant that problems with supply exist. There are problems with quantification of needs and equitable distribution of insulin. Problems with availability of syringes and testing equipment were noted, particularly in Mozambique. This lack of tools and infrastructure for diagnosis and follow-up coupled with low levels of health care worker training and lack of diagnostic reagents resulted in a substantial risk of misdiagnosis or failure to detect diabetes. The estimated prevalence of insulin-requiring diabetes differs more than 10-fold between urban and rural areas in Mozambique and 4-fold between Mozambique and Zambia, suggesting that problems in diagnosis and care result in substantial worsening of prognosis for such patients. CONCLUSIONS—Insulin is necessary but not sufficient to improve prognosis for diabetic patients. A Rapid Assessment Protocol methodology can be used to define problems in health care delivery for diabetes. Proper care for insulin-requiring diabetes necessitates health systems able to provide trained personnel, medicines in sufficient quantity, and diagnostic and monitoring facilities.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Mozambique, the life expectancy for a newly diagnosed child with type 1 diabetes is 7 months.
“For example, in Mozambique, the life expectancy for a newly diagnosed child with type 1 diabetes is 7 months.123”
From Type 1 diabetes (2014) · cites this paper as [123]
In “Estimates of prevalence and prognosis” (Table 2; page not specified), the paper estimates 0.6 years—about seven months—for a child aged 0–14 with insulin-requiring diabetes in rural Mozambique. The claim omits the rural restriction: the paper’s national estimate for that age group is 3.5 years. The table also does not specify newly diagnosed children with type 1 diabetes. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,713 · see citing works
Gregory, G. A., Robinson, T. I. G., Linklater, S. E., Wang, F., Colagiuri, S., de Beaufort, C., Donaghue, K. C., Harding, J. L., Wander, P. L., Zhang, X., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00218-2 · Cited by 1,149 · see citing works
What can global health institutions do to help strengthen health systems in low income countries?
Balabanova, D., McKee, M., Mills, A., Walt, G., & Haines, A. (2010) · Health Research Policy and Systems · doi:10.1186/1478-4505-8-22 · Cited by 130 · see citing works
Murphy, A., Chikovani, I., Uchaneishvili, M., Makhashvili, N., & Roberts, B. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3113-y · Cited by 31 · see citing works
- Authors
- Beran, D., Yudkin, J. S., & de Courten, M.
- Affiliations
- From the International Insulin Foundation, London, U.K.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-09-01
- Volume
- 28
- Issue
- 9
- Pages
- 2136-2140
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2101993369
- Cited by
- 203
- References
- 1
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 33 · 2021: 14 · 2020: 9 · 2019: 11 · 2018: 13 · 2017: 9 · 2016: 14 · 2015: 15 · 2014: 8 · 2013: 17 · 2012: 7
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Victoria University Research Repository (Victoria University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- World Health Organization
- University College London
- World Diabetes Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- insulin-treated diabetes, health care access, barriers to care, health care financing, health care worker training, diagnostic reagents, diabetes misdiagnosis, urban-rural disparities, diabetes prevalence, Mozambique, Zambia, developing countries
- MeSH terms
- Developing Countries, Diabetes Mellitus, Type 1, Health Personnel, Health Services, Health Services Accessibility, Humans, Hypoglycemic Agents, Insulin, Health Knowledge, Attitudes, Practice, Mozambique, Prognosis, Zambia, Prevalence, Medicine, African Traditional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review